Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Advaxis Inc. (OTC : ADXS) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.
Quote
| Last: | $0.6195 |
|---|---|
| Change Percent: | 3.25% |
| Open: | $0.6 |
| Close: | $0.60 |
| High: | $0.6195 |
| Low: | $0.6 |
| Volume: | 8,356 |
| Last Trade Date Time: | 02/03/2026 12:49:35 pm |
Stock Data
| Market Cap: | $25,731,389 |
|---|---|
| Float: | 21,452,274 |
| Insiders Ownership: | N/A |
| Institutions: | 8 |
| Short Percent: | 39892% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.ayalapharma.com |
| Country: | US |
| City: | Monmouth Junction |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : Bigstud is here
investorshub : bme
investorshub : Renee
investorshub : willlbone
**MWN-AI FAQ is based on asking OpenAI questions about Advaxis Inc. (OTC: ADXS).
